Clinical Research Directory
Browse clinical research sites, groups, and studies.
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
This randomized non-inferiority study will use a 2x2 design where traditional standard-of-care pre-test (visit 1) and post-test (visit 2: disclosure) counseling delivered by a genetic counselor are replaced with a self-directed web-based eHealth intervention to provide critical data to inform optimal ways to deliver clinical genetic testing in eligible individuals, while maintaining quality of care and favorable cognitive, affective and behavioral outcomes.
Official title: A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2022-09-28
Completion Date
2026-07-01
Last Updated
2026-01-16
Healthy Volunteers
Yes
Conditions
Interventions
Pre-Test Intervention
Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.
Standard of Care
Standard of Care with a Genetic Counselor by Remote Services
Post-Test Intervention
Secure and accessible by private code only, the web-based intervention will provide users with a the results of their clinical genetic testing results and a detailed summary of what those results mean. Additionally, an individualized summary will also be included.
Locations (1)
Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States